Initial Public Offering (Details) - USD ($)			3 Months Ended
	Jul. 14, 2021	Jul. 01, 2021	Mar. 31, 2022	Dec. 31, 2021	Mar. 31, 2021
Subsidiary, Sale of Stock [Line Items]
Sale of Stock, Underwriting fees	$ 1,000,000
Deferred underwriting fee payable	1,750,000
Number of shares issued			750,000
Shares subject to possible redemption			28,750,000
Contingently redeemable ordinary share			$ 255,454,933	$ 255,434,087
Initial Public Offering
Subsidiary, Sale of Stock [Line Items]
Sale of Stock, Underwriting fees		$ 1,000,000
Deferred underwriting fee payable		$ 1,750,000
Over-allotment
Subsidiary, Sale of Stock [Line Items]
Sale of Stock, Underwriting fees	1,108,507
Deferred underwriting fee payable	$ 1,939,888
Class A Common Stock | Initial Public Offering
Subsidiary, Sale of Stock [Line Items]
Sale of Units, net of underwriting discounts (in shares)		25,000,000
Purchase price, per unit		$ 10.00
Proceeds received from public offerings, net of underwriters' discount		$ 250,000,000
Class A Common Stock | Over-allotment
Subsidiary, Sale of Stock [Line Items]
Sale of Units, net of underwriting discounts (in shares)	542,537
Purchase price, per unit	$ 10.00
Proceeds received from public offerings, net of underwriters' discount	$ 5,425,370
Number of shares issued	542,537
Proceeds from Issuance of Common Stock	$ 5,425,370
Class A ordinary shares subject to possible redemption.
Subsidiary, Sale of Stock [Line Items]
Shares subject to possible redemption			25,542,537	25,542,537	25,542,537
Gross proceeds from IPO			$ 255,425,370
Ordinary share issuance costs			(3,657,600)
Initial measurement of carrying value to redemption value			3,657,600
Subsequent remeasurement of carrying value to redemption value			29,563
Contingently redeemable ordinary share			$ 255,454,933
Sponsor
Subsidiary, Sale of Stock [Line Items]
Sale of Units, net of underwriting discounts (in shares)		20,000,000